Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
06:33pm, Wednesday, 03'rd Jan 2024
EMERYVILLE, Calif. , Jan. 3, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, tod
Dynavax Technologies: Still A Solid Pick For 2024
01:53pm, Tuesday, 02'nd Jan 2024
Today, we take another look at Dynavax Technologies Corporation, which experienced a boost in revenue from the Covid pandemic, but this has now nearly completely diminished. However, the company's cor
20 favorite small-cap stocks for 2024 among Wall Street analysts
12:18pm, Tuesday, 26'th Dec 2023
The 2023 stock-market rally has been led by the “Magnificent Seven” companies, which have driven an accelerating upward trend for the large-cap benchmark S&P 500. Shares of smaller and medium-size
3 Biotech Stocks Most Wall Street Analysts Are Bullish About
10:31am, Monday, 18'th Dec 2023
Here we present three biotech stocks, CRSP, ITCI and DVAX, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2024, backed by strong fundamentals.
Can Dynavax Technologies (DVAX) Climb 91.59% to Reach the Level Wall Street Analysts Expect?
11:17am, Tuesday, 05'th Dec 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 91.6% in Dynavax Technologies (DVAX). While the effectiveness of this highly sought-after metric is questionabl
Is Dynavax Technologies (DVAX) Stock Outpacing Its Medical Peers This Year?
11:17am, Friday, 24'th Nov 2023
Here is how Dynavax Technologies (DVAX) and Exscientia PLC Sponsored ADR (EXAI) have performed compared to their sector so far this year.
5 Biotech Stocks Likely to Thrive as Industry Prospects Look Bright
09:46am, Wednesday, 22'nd Nov 2023
New drug approvals and pipeline progress are likely to help maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position GILD, CRSP, ACAD,
Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference
05:04pm, Monday, 20'th Nov 2023
EMERYVILLE, Calif. , Nov. 20, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, t
Is Dynavax Technologies (DVAX) Outperforming Other Medical Stocks This Year?
11:17am, Tuesday, 07'th Nov 2023
Here is how Dynavax Technologies (DVAX) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Dynavax Technologies Corporation (DVAX) Q3 2023 Earnings Call Transcript
07:07pm, Thursday, 02'nd Nov 2023
Start Time: 16:30 January 1, 0000 4:59 PM ET Dynavax Technologies Corporation (NASDAQ:DVAX ) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 PM ET Company Participants Ryan Spencer - CEO Don
Dynavax (DVAX) to Report Q3 Earnings: Will It Beat Estimates?
09:01am, Tuesday, 24'th Oct 2023
On Dynavax's (DVAX) third-quarter earnings call, investors' focus is likely to be on the sales performance of the company's hepatitis B vaccine, HEPLISAV-B.
Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference
01:15pm, Thursday, 19'th Oct 2023
EMERYVILLE, Calif., Oct. 19, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, tod
Is it a Good Idea to Invest in Dynavax (DVAX) Stock Now?
08:16am, Thursday, 19'th Oct 2023
Here, we discuss some reasons why investing in Dynavax Technologies (DVAX) stock now may turn out to be a prudent move.
Here's Why Momentum in Dynavax Technologies (DVAX) Should Keep going
10:32am, Monday, 16'th Oct 2023
Dynavax Technologies (DVAX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed t
Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 73.92%: Read This Before Placing a Bet
11:16am, Friday, 29'th Sep 2023
The consensus price target hints at a 73.9% upside potential for Dynavax Technologies (DVAX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earni
